FDA Inspection
CCRM Seattle LLCCCRM Seattle LLC – FDA Inspection, Apr 19, 2016
Record Details
This FDA Inspection record concerns CCRM Seattle LLC, with an inspection on April 19, 2016, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- CCRM Seattle LLC
- Inspection Date
- April 19, 2016
- Product Type
- Biologics
View Company Profile
ID · 4c39c574-df74-47e3-b1a1-80e501206be5
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 967310
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
FDA Citations
2- 21 CFR 1271.50(a)Determination based on screening and testing
- 21 CFR 1271.50(a)Responsible person to determine, document
Full citation text and observation details available on the Dashboard.
Other FDA inspections of CCRM Seattle LLC
6| Date | Classification | Office | Project area |
|---|---|---|---|
| August 13, 2026 | Not classified | Seattle District Office | Human Cellular, Tissue, and Gene Therapies |
| March 23, 2023 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| September 27, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| December 9, 2014 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| January 17, 2014 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for CCRM Seattle LLC
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.